COVID-19 and its psychological consequences: Beware of the respiratory subtype of panic disorder

Javelot, Hervé; Weiner, Luisa; Hingray, Coraline; Freire, Rafael C.; Nardi, Antônio Egídio

doi:10.1016/j.resp.2020.103530

Cited by 4 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, concerning panic disorder and the COVID-19 pandemic, it would be interesting to follow both the overall evolution of this disorder, but also the specific prevalence rate of the respiratory subtype. While several studies have investigated the psychological consequences of the current pandemic, to date very few studies have focused on panic disorder specifically [32,163]. This might seem surprising given the predominance of respiratory symptoms in both COVID-19 and panic disorder, on the one hand, and the generalized fear of contamination and fear of suffocation heightened by the pandemic, on the other hand [32,163].…”

Section: Anxiety Disordersmentioning

confidence: 99%

“…While several studies have investigated the psychological consequences of the current pandemic, to date very few studies have focused on panic disorder specifically [32,163]. This might seem surprising given the predominance of respiratory symptoms in both COVID-19 and panic disorder, on the one hand, and the generalized fear of contamination and fear of suffocation heightened by the pandemic, on the other hand [32,163]. Salbutamol, a short-acting β-stimulant can be overused in many situations; in patients with asthma, in comorbid situations with asthma and panic disorder (or the latter disorder alone misdiagnosed as asthma) or in the respiratory subtype of panic disorder [33].…”

Section: Anxiety Disordersmentioning

confidence: 99%

See 1 more Smart Citation

Psychotropics and COVID-19: An analysis of safety and prophylaxis

et al. 2021

View full text Add to dashboard Cite

The use of psychotropics during the COVID-19 pandemic has raised two questions, in order of importance: first, what changes should be made to pharmacological treatments prescribed to mental health patients? Secondly, are there any positive side effects of these substances against SARS-CoV-2? Our aim was to analyze usage safety of psychotropics during COVID-19, therefore herein we have studied: (i) the risk of symptomatic complications of COVID-19 associated with the use of these drugs, notably central nervous system activity depression, QTc interval enlargement and infectious and thromboembolic complications, (ii) the risk of mistaking the iatrogenic impact of psychotropics with COVID-19 symptoms, causing diagnostic error. Moreover, we provided a summary of the different information available today for these risks, categorized by mental health disorder, for the following: schizophrenia, bipolar disorder, anxiety disorder, ADHD, sleep disorders and suicidal risk. The matter of psychoactive substance use during the pandemic is also analyzed in this paper, and guideline websites and publications for psychotropic treatments in the context of COVID-19 are referenced during the text, so that changes on those guidelines and eventual interaction between psychotropics and COVID-19 treatment medication can be reported and studied. Finally, we also provide a literature review of the latest known antiviral properties of psychotropics against SARS-CoV-2 as complementary information.

show abstract

Section: Anxiety Disordersmentioning

confidence: 99%

Section: Anxiety Disordersmentioning

confidence: 99%

Psychotropics and COVID-19: An analysis of safety and prophylaxis

et al. 2021

View full text Add to dashboard Cite

show abstract

“…For example, COVID-19 patients who struggle with breathlessness and the fear of suffocation may be at particular risk of developing panic attacks. In people who did not suffer from COVID-19, excessive vigilance towards respiratory symptoms and fear of suffocation may also be associated with the onset or worsening of panic symptoms [29].…”

Section: Panic Disorders In the Covid-19 Pandemicmentioning

confidence: 99%

The impact of the COVID-19 pandemic on the development of anxiety disorders - a literature review

Koch

Chmielowiec

Grzywacz

et al. 2021

Current Problems of Psychiatry

View full text Add to dashboard Cite

Introduction: The COVID-19 is a disease caused by the SARS-CoV-2 virus. A number of psychological symptoms have been identified in people living during the COVID-19 pandemic. Most of them are associated with widely understood anxiety disorders, which have always been a significant problem for mental health. Materials and methods: The available literature was reviewed on the Pubmed platform and from other sources. The analysis included original studies, reviews, meta-analyzes and internet sources. The aim of the study was to review the literature on the relationship between the COVID-19 pandemic and the occurrence and severity of symptoms of anxiety disorders. Results: The studies conducted so far show that the COVID-19 pandemic has had a significant impact on the mental state of people around the world, especially in the area of anxiety disorders. Many studies indicate an increase in the prevalence of symptoms of generalized anxiety disorder. Research also indicates a greater incidence of post-traumatic stress disorder and panic disorder in society. Symptoms of somatization were also quite often observed in patients. However, the state of published studies indicates that the pandemic did not significantly affect the severity of symptoms associated with social phobia. In the context of phobic disorders, a new type has been formulated: COVID-19-related phobia. Conclusions: The conducted literature review shows that the current COVID-19 pandemic is associated with an increase in the prevalence of symptoms of anxiety disorders in the general population. The multifaceted nature of the issue of anxiety disorders in the COVID-19 pandemic clearly indicates the need to continue research in this area.

show abstract

The Bergen 4-day treatment for panic disorder: adapting to COVID-19 restrictions with a hybrid approach of face-to-face and videoconference modalities

et al. 2023

View full text Add to dashboard Cite

Background The Bergen 4-day treatment (B4DT) is a concentrated exposure-based therapy that has been shown to be effective in the treatment of anxiety disorders. The current study sought to examine the effectiveness of B4DT for panic disorder (PD), when delivered with a combination of face-to-face sessions and videoconferencing. Methods Treatment was delivered to 50 patients from April 2020 to May 2021. Because of regulations during the pandemic, a significant portion of the treatment was conducted via videoconference. The primary outcome measure was the clinician-rated Panic Disorder Severity Scale (PDSS), and secondary measures included patient-rated symptoms of panic disorder, agoraphobia, generalized anxiety, depression, and treatment satisfaction. Changes in symptom levels over time were estimated using multilevel models. Results Patients showed a significant reduction in clinician-rated symptoms of panic disorder (Measured by PDSS) from before treatment to post treatment (d = 2.18) and 3-month follow-up (d = 2.01). At three months follow-up 62% of patients were classified as in remission, while 70% reported a clinically significant response. We also found a reduction in symptoms of depression and generalized anxiety, and the patients reported high satisfaction with the treatment. Conclusion The current study suggests that B4DT delivered in a combination of videoconference and face-to-face meetings may be a useful treatment approach. As the study is uncontrolled, future studies should also include more strictly designed investigations.

show abstract

COVID-19 and its psychological consequences: Beware of the respiratory subtype of panic disorder

Abstract: Highlights COVID-19 could increase the rates of the respiratory subtype of panic disorder.

Cited by 4 publications

References 6 publications

Psychotropics and COVID-19: An analysis of safety and prophylaxis

Psychotropics and COVID-19: An analysis of safety and prophylaxis

The impact of the COVID-19 pandemic on the development of anxiety disorders - a literature review

The Bergen 4-day treatment for panic disorder: adapting to COVID-19 restrictions with a hybrid approach of face-to-face and videoconference modalities

Contact Info

Product

Resources

About